TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
GANX

Gain Therapeutics Inc

Healthcare · Biotechnology

1.80$ -5.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GANX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
0.00 0.00 0.00 0.02 0.01 0.00 0.00 0.00
– – 0.19 0.70 0.69 0.01 0.00 0.00
0.00 0.00 0.00 0.02 0.01 0.00 0.00 0.00
0.14 0.19 0.19 0.70 0.70 0.89 0.47 0.31
0.04 0.07 0.11 0.67 0.80 0.83 0.42 0.26
0.18 0.26 0.30 1.38 1.51 1.71 0.89 0.57
-0.18 -0.25 -0.29 -1.36 -1.50 -1.71 -0.89 -0.57
0.01 0.00 0.02 0.01 0.02 – – –
-0.19 -0.26 -0.30 -1.37 -1.47 -1.71 -0.87 -0.59
0.00 0.00 0.00 0.00 0.01 0.01 0.02 0.03
-0.19 -0.26 -0.30 -1.37 -1.48 -1.71 -0.89 -0.61
-0.18 -0.25 -0.29 -1.36 -1.47 -1.70 -0.86 -0.58

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?